Download PDF
Thromb Haemost 1973; 29(01): 003-010
DOI: 10.1055/s-0038-1647741
Original Article
Schattauer GmbH

Clinical Trials with Antithrombotic and Thrombolytic Agents

Principles and Pitfalls[*]
Sol Sherry
1   Department of Medicine and the Specialized Center for Thrombosis Research, Temple University School of Medicine Philadelphia, Pennsylvania
› Author Affiliations
Further Information

Publication History

Received 01 November 1972

Publication Date:
30 June 2018 (online)

Also available at
    Permissions and Reprints

 

* Presented at the Third Congress of the International Society on Thrombosis and Haemostasis.


 

  • References

  • 1 Bass N. Personal communication.
    PubMed
  • 2 Dioguardi N, Lotto A, Levi G. F. 1971 Controlled trial of streptokinase and heparin in acute myocardial infarction. Lancet. 02. 891.
    PubMedSearch in Google Scholar
  • 3 European Working Party. 1971; Streptokinase in acute myocardial infarction. A controlled multicentre trial. British Medical Journal 02: 325.
    PubMedSearch in Google Scholar
  • 4 Hale G. S. 1970 Streptokinase in acute myocardial infarction. Rationale and preliminary results of a combined therapeutic trial. Australian Annals of Medicine. 19. suppl. 1, 63 and personal communication.
    PubMedSearch in Google Scholar
  • 5 Heikinheimo R, Ahrenberg P, Honkapohja H. 1971; Fibrinolytic treatment in acute myocardial infarction. Acta Medica Scandinavica 189: 7.
    PubMedSearch in Google Scholar
  • 6 Schmutzler R, Fritze E, Gebauer D. 1970 Fibrinolytic therapy of acute myocardial infarction. XIII International Congress of Hematology. Munich August. 2-8. 1970.
    PubMedSearch in Google Scholar
  • 7 Schmutzler R, Hecknee F, Kortge P. 1966; Thrombolytic Therapy of recent myocardial infarction. I. Introduction, plan of trial, general clinical results. German Medical Monthly 11: 308.
    PubMedSearch in Google Scholar